Get Healthy!

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

April 9, 2025
HealthDayTV HealthDay Reporter

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Multiple Sclerosis Brain

Health News is provided as a service to Pelham Pharmacy site users by HealthDay. Pelham Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Patient Resources

Get Healthy!

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

Health News is provided as a service to Pelham Pharmacy site users by HealthDay. Pelham Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags

(215) 848-0500

Toll-Free (855) 756-7999

Patient Resources

Get Healthy!

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

Health News is provided as a service to Pelham Pharmacy site users by HealthDay. Pelham Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags